Spots Global Cancer Trial Database for multiple sclerosis

Every month we try and update this database with for multiple sclerosis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Study Evaluating Mitoxantrone in Multiple Sclerosis	NCT00146159	Secondary Progr...	Mitoxantrone	18 Years - 55 Years	Wyeth is now a wholly owned subsidiary of Pfizer
Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures	NCT02777060	Diabetes Cancer Multiple Sclero... Arthritis Parkinson's Dis... Cognitive Disor... Brain Injury Stroke	Exergame Home based bala...	18 Years -	University of Arizona
Evaluate the Safety and Feasibility of Allogeneic Mesenchymal Stem Cells in Patients With Multiple Sclerosis	NCT06360861	Multiple Sclero... Secondary-Progr... Mesenchymal Ste...	Allogenic place...	17 Years - 45 Years	Tehran University of Medical Sciences
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer	NCT03816345	Autoimmune Dise... Crohn Disease Dermatomyositis Hematopoietic a... Inflammatory Bo... Malignant Solid... Multiple Sclero... Psoriasis Psoriatic Arthr... Rheumatoid Arth... Sjogren Syndrom... Systemic Lupus ... Systemic Sclero... Ulcerative Coli...	Biospecimen Col... Nivolumab	18 Years -	National Cancer Institute (NCI)
A Study of Anti-CD19 CAR T-Cell Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis	NCT06384976	Multiple Sclero... Multiple Sclero... Multiple Sclero...	KYV-101 Standard lympho... Anti-CD20 mAB	18 Years - 60 Years	Kyverna Therapeutics
PatientSpot Formerly Known as ArthritisPower	NCT03840928	Rheumatoid Arth... Ankylosing Spon... Fibromyalgia Gout Crohn Disease Juvenile Idiopa... Lupus Erythemat... Myositis Osteoarthritis Osteoporosis Psoriasis Psoriatic Arthr... Scleroderma Dermatomyositis Inflammatory Bo... Polymyositis Axial Spondyloa... Diffuse Idiopat... Polymyalgia Rhe... Giant Cell Arte... Temporal Arteri... Wegener Relapsing Polyc... Undifferentiate... Spinal Cord Inj... Alzheimer Disea... Amyotrophic Lat... Ataxia Bell Palsy Brain Tumor Cerebral Aneury... Epilepsy Guillain-Barre ... Headache Head Injury Hydrocephalus Lumbar Disc Dis... Meningitis Multiple Sclero... Muscular Dystro... Neurocutaneous ... Parkinson Disea... Stroke Cluster Headach... Tension-Type He... Chronic Obstruc... Asthma Lung Cancer Cystic Fibrosis Sleep Apnea Eczema Alopecia Chronic Inflamm... Unstable Angina Heart Attack Heart Failure Arrythmia Valve Heart Dis... High Blood Pres... Congenital Hear... Peripheral Arte... Diabetes Chronic Liver D... Obesity		19 Years -	Global Healthy Living Foundation
Phase 1b Multiple Ascending Dose Study of Foralumab in Primary and Secondary Progressive MS	NCT05029609	Primary Progres... Secondary Progr... Multiple Sclero...	Intranasal Fora... Placebo	25 Years - 70 Years	Tiziana Life Sciences LTD
Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity	NCT03941184	SCAD Addison Disease Ankylosing Spon... Antiphospholipi... Celiac Disease Crohn Disease Dermatomyositis Polymyositis Guillain-Barre ... Hepatitis, Auto... Graves Disease Hashimoto Thyro... Multiple Sclero... Myasthenia Grav... Pernicious Anem... Polymyalgia Rhe... Primary Biliary... Psoriasis Rheumatoid Arth... Systemic Sclero... Sjögren Syndrom... Systemic Lupus ... Takayasu Arteri... Type 1 Diabetes... Ulcerative Coli... Uveitis Vasculitis Vitiligo Raynaud		18 Years - 110 Years	Mayo Clinic
Drugs for the Treatment of Multiple Sclerosis and Risk of Cancer: a Pharmacovigilance Analysis in Vigibase	NCT04237337	Multiple Sclero... Malignant Tumor	Exposure to MS ...	-	University Hospital, Caen
Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System	NCT04561557	Autoimmune Dise... Autoimmune Dise... Neuromyelitis O... Myasthenia Grav... Chronic Inflamm... Idiopathic Infl... Multiple Sclero... Autoimmune Ence... Myelin Oligoden... POEMS Syndrome	CT103A cells Cyclophosphamid...	18 Years - 75 Years	Tongji Hospital
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives	NCT05635266	Age-Related Mac... Allergies Alpha-Gal Syndr... Alzheimer Disea... Amyloidosis Ankylosing Spon... Arthritis Alopecia Areata Asthma Atopic Dermatit... Autism Autoimmune Hepa... Behcet's Diseas... Beta-Thalassemi... Cancer Celiac Disease Kidney Diseases COPD Crohn Disease Cystic Fibrosis Diabetes Dravet Syndrome DMD Fibromyalgia Graves Disease Thyroid Disease... Hepatitis Hidradenitis Su... ITP Leukemia ALS Lupus or SLE Lymphoma Multiple Sclero... Myasthenia Grav... Heart Diseases Parkinson Disea... Pemphigus Vulga... Cirrhosis Psoriasis Schizophrenia Scleroderma Sickle Cell Dis... Stroke Ulcerative Coli... Vasculitis Vitiligo	Specimen sample	18 Years - 85 Years	Sanguine Biosciences
Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases	NCT02967380	Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Choroid P... Adult Diffuse A... Adult Ependymob... Adult Ependymom... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Grade II ... Adult Medullobl... Adult Mixed Gli... Adult Oligodend... Adult Papillary... Adult Pineal Gl... Adult Pineoblas... Adult Primary M... Adult Supratent... Malignant Adult... Metastatic Mali... Multiple Sclero... Recurrent Adult...	Dynamic Contras... Gadobenate Dime... Gadobutrol Gadopentetate D...	18 Years -	University of Southern California
Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People	NCT04844489	Autoimmune or A... HIV Multiple Sclero... Solid Tumors or... Solid Organ Tra...	Blood samples f...	18 Years -	Assistance Publique - Hôpitaux de Paris
Cladribine vs Placebo for Non-active Progressive Multiple Sclerosis (CLASP-MS).	NCT05961644	Multiple Sclero... Multiple Sclero...	Cladribine Subc... 0.9% Chloride I...	30 Years - 65 Years	Institute of Psychiatry and Neurology, Warsaw
Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen	NCT04940065	Relapsing-remit... Active Secondar...	Kesimpta	- 99 Years	Novartis
Quality Improvement and Practice Based Research in Neurology Using the EMR	NCT02670161	Brain Tumors Epilepsy Migraine Mild Cognitive ... Concussion Multiple Sclero... Neuropathy Parkinson's Restless Legs S... Stroke	Listed for each...	18 Years - 100 Years	NorthShore University HealthSystem
A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Participants With Secondary Progressive Multiple Sclerosis	NCT01416181	Secondary Progr...	natalizumab Placebo	18 Years - 58 Years	Biogen
Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis	NCT01684761	Autoimmune Dise... Multiple Sclero... Secondary Progr... Disease Progres... Brain Atrophy	Tcelna Placebo	18 Years - 60 Years	Opexa Therapeutics, Inc.
A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Participants With Secondary Progressive Multiple Sclerosis	NCT01416181	Secondary Progr...	natalizumab Placebo	18 Years - 58 Years	Biogen
Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults	NCT04952766	Kidney Transpla... Myeloma Cancer Hematologic Mal... Multiple Sclero... Hypergammaglobu... Malignant Tumor Hiv Diabetes Type 2	Biological samp...	18 Years -	Centre Hospitalier Régional d'Orléans
Biobank For MS And Other Demyelinating Diseases	NCT00445367	Multiple Sclero... Transverse Myel... Neuromyelitis O... Acute Dissemina... Optic Neuritis		-	Accelerated Cure Project for Multiple Sclerosis
An Exploratory Study to Evaluate Attention Biases in Adults With Multiple Sclerosis, Breast Cancer, and Lung Cancer	NCT06136923	Multiple Sclero... Lung Cancer Breast Cancer	CT-100-D-004-A CT-100-D-004-B	22 Years - 65 Years	Click Therapeutics, Inc.
Increasing Diagnosis Rates While Reducing Examination Time: Can MR Fingerprinting Deliver on Its Promise?	NCT06251830	Neurodevelopmen... Neurodegenerati... Brain Tumor Multiple Sclero... Epilepsy	MRI exam with M...	4 Years -	IRCCS Fondazione Stella Maris
Efficacy and Safety of Masitinib in the Treatment of Progressive Multiple Sclerosis	NCT01433497	Multiple Sclero... Multiple Sclero... Multiple Sclero...	Masitinib Placebo	18 Years - 75 Years	AB Science
Neurology Inpatient Clinical Education Trial	NCT03826056	Myasthenia Grav... Guillain-Barre ... Multiple Sclero... Seizures Parkinsonism Meningitis Encephalitis Headache Vestibular Diso... Spondylosis Normal Pressure...	Current standar... Personalized di...	18 Years - 95 Years	Dartmouth-Hitchcock Medical Center
Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease	NCT03656627	Autoimmune Dise... Non-small Cell ... Rheumatoid Arth... Psoriasis Giant Cell Arte... Polymyalgia Rhe... Systemic Lupus ... Crohn Disease Multiple Sclero... Ulcerative Coli...	Nivolumab	18 Years -	Alliance Foundation Trials, LLC.
Timing of Acute Palliative Care Consultation in Critically Ill Patients	NCT02858778	Multiple Organ ... End Stage Cardi... End Stage Chron... Chronic Kidney ... Hepatic Encepha... Sepsis Dementia Multiple Sclero... Parkinson's Dis... In-Hospital Car... Solid Organ Can...	Early order of ...	65 Years -	Wayne State University
Serum Auto-Antibodies in Neurological Diseases	NCT00704626	Multiple Sclero... Myasthenia Grav... Transverse Myel...	Blood Draw Cheek swab	18 Years -	University of California, Davis
Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple Sclerosis	NCT02228213	Secondary Progr...	MIS416 Saline	18 Years - 70 Years	Innate Immunotherapeutics
Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People	NCT04844489	Autoimmune or A... HIV Multiple Sclero... Solid Tumors or... Solid Organ Tra...	Blood samples f...	18 Years -	Assistance Publique - Hôpitaux de Paris
Study Evaluating Mitoxantrone in Multiple Sclerosis	NCT00146159	Secondary Progr...	Mitoxantrone	18 Years - 55 Years	Wyeth is now a wholly owned subsidiary of Pfizer
Early Detection and Paramedical Care of Sexual Difficulties in Nervous System Diseases: Example of Multiple Sclerosis and Brain Tumors (NEUROSEX)	NCT03154801	Low Grade Gliom... Multiple Sclero... Sexual Dysfunct...	Paramedical car...	18 Years -	Assistance Publique - Hôpitaux de Paris
Quality Improvement and Practice Based Research in Neurology Using the EMR	NCT02670161	Brain Tumors Epilepsy Migraine Mild Cognitive ... Concussion Multiple Sclero... Neuropathy Parkinson's Restless Legs S... Stroke	Listed for each...	18 Years - 100 Years	NorthShore University HealthSystem
Novel Imaging Markers in SPMS	NCT05357833	Secondary Progr... Multiple Sclero... Multiple Sclero...	Ferumoxytol inf... Gadoteridol MRI Brain and C...	35 Years - 65 Years	University of Utah
Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases	NCT02967380	Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Choroid P... Adult Diffuse A... Adult Ependymob... Adult Ependymom... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Grade II ... Adult Medullobl... Adult Mixed Gli... Adult Oligodend... Adult Papillary... Adult Pineal Gl... Adult Pineoblas... Adult Primary M... Adult Supratent... Malignant Adult... Metastatic Mali... Multiple Sclero... Recurrent Adult...	Dynamic Contras... Gadobenate Dime... Gadobutrol Gadopentetate D...	18 Years -	University of Southern California
Measuring Cerebral Blood Flow Using Pseudo-continuous Arterial Spin Labeling Perfusion Magnetic Resonance Imaging	NCT02767609	Traumatic Brain... Multiple Sclero... Alzheimer's Dis... Tumor	Magnetic Resona...	18 Years - 90 Years	Loma Linda University
NYSCF Scientific Discovery Biobank	NCT06203106	ALS Amyotrophic Lat... Alzheimer Disea... Alzheimer Disea... Alzheimer Disea... Batten Disease Corticobasal De... Dementia Frontotemporal ... Huntington Dise... Lewy Body Disea... Multiple Sclero... Multiple System... Parkinson Disea... Parkinson's Dis... Progressive Sup... INAD Diabetes Diabetes Mellit... Diabetes Mellit... Diabetes Mellit... Macular Degener... Ovarian Cancer Cervical Cancer Uterine Cancer Vaginal Cancer Vulvar Cancer PTSD Post Traumatic ...	Biological Samp...	30 Days -	New York Stem Cell Foundation Research Institute
AIM's Writing for Healing: A Workshop for Individuals Living With Paralysis	NCT04721717	Spinal Cord Inj... Multiple Sclero... Transverse Myel... Amyotrophic Lat...		18 Years -	University of Alabama at Birmingham
Remote Neuropsychological Assessment of Patients With Neurological Disorders and Injuries	NCT05819008	Traumatic Brain... Stroke Multiple Sclero... Parkinson Disea... Epilepsy Brain Tumor	Neuropsychologi...	18 Years -	Umeå University
Biobank For MS And Other Demyelinating Diseases	NCT00445367	Multiple Sclero... Transverse Myel... Neuromyelitis O... Acute Dissemina... Optic Neuritis		-	Accelerated Cure Project for Multiple Sclerosis
An Observational Post-Marketing Safety Registry of Sativex®	NCT02073474	Multiple Sclero... Diabetes Cancer Neuropathic Pai...	Sativex®	-	Jazz Pharmaceuticals
Efficacy and Safety of MBP8298 in Subjects With Secondary Progressive Multiple Sclerosis	NCT00468611	Multiple Sclero...	MBP8298	18 Years - 65 Years	BioMS Technology Corp.
An Exploratory Study to Evaluate Attention Biases in Adults With Multiple Sclerosis, Breast Cancer, and Lung Cancer	NCT06136923	Multiple Sclero... Lung Cancer Breast Cancer	CT-100-D-004-A CT-100-D-004-B	22 Years - 65 Years	Click Therapeutics, Inc.
Cladribine vs Placebo for Non-active Progressive Multiple Sclerosis (CLASP-MS).	NCT05961644	Multiple Sclero... Multiple Sclero...	Cladribine Subc... 0.9% Chloride I...	30 Years - 65 Years	Institute of Psychiatry and Neurology, Warsaw
Biobank For MS And Other Demyelinating Diseases	NCT00445367	Multiple Sclero... Transverse Myel... Neuromyelitis O... Acute Dissemina... Optic Neuritis		-	Accelerated Cure Project for Multiple Sclerosis
Home Based Tele-exercise for People With Chronic Neurological Impairments	NCT04564495	Neurologic Diso... Stroke Spinal Cord Inj... Cerebral Palsy Hemiplegia Hemiparesis Multiple Sclero... Parkinson Disea... Trauma, Brain Transverse Myel... Friedreich Atax...	Seated exercise	18 Years - 75 Years	Burke Medical Research Institute
Early Detection and Paramedical Care of Sexual Difficulties in Nervous System Diseases: Example of Multiple Sclerosis and Brain Tumors (NEUROSEX)	NCT03154801	Low Grade Gliom... Multiple Sclero... Sexual Dysfunct...	Paramedical car...	18 Years -	Assistance Publique - Hôpitaux de Paris
Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System	NCT04561557	Autoimmune Dise... Autoimmune Dise... Neuromyelitis O... Myasthenia Grav... Chronic Inflamm... Idiopathic Infl... Multiple Sclero... Autoimmune Ence... Myelin Oligoden... POEMS Syndrome	CT103A cells Cyclophosphamid...	18 Years - 75 Years	Tongji Hospital
Exploring Accessible Beauty for Individuals With Upper Extremity Deficits	NCT05945784	Stroke, Ischemi... Stroke Hemorrha... Stroke (CVA) or... Stroke, Acute Traumatic Brain... SCI - Spinal Co... Ehlers-Danlos S... Lupus Erythemat... Guillain-Barre ... Multiple Sclero... Myasthenia Grav... Amyotrophic Lat... Graves Disease Muscular Dystro...	Use of Rare Bea...	18 Years - 55 Years	Casa Colina Hospital and Centers for Healthcare
Effects of a CT-100 DiNaMo Component on Cognitive Functioning and Mood Symptoms	NCT05438147	Multiple Sclero... Mild Cognitive ... Cancer	CT-100 DiNaMo Care-as-Usual	22 Years - 75 Years	Click Therapeutics, Inc.
Early Detection and Paramedical Care of Sexual Difficulties in Nervous System Diseases: Example of Multiple Sclerosis and Brain Tumors (NEUROSEX)	NCT03154801	Low Grade Gliom... Multiple Sclero... Sexual Dysfunct...	Paramedical car...	18 Years -	Assistance Publique - Hôpitaux de Paris
Novel Imaging Markers in SPMS	NCT05357833	Secondary Progr... Multiple Sclero... Multiple Sclero...	Ferumoxytol inf... Gadoteridol MRI Brain and C...	35 Years - 65 Years	University of Utah
Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone	NCT00004645	Acute Dissemina... Devic's Syndrom... Marburg's Varia... Balo's Concentr... Acute Transvers...	Plasma exchange	18 Years - 60 Years	Office of Rare Diseases (ORD)
Home Based Tele-exercise for People With Chronic Neurological Impairments	NCT04564495	Neurologic Diso... Stroke Spinal Cord Inj... Cerebral Palsy Hemiplegia Hemiparesis Multiple Sclero... Parkinson Disea... Trauma, Brain Transverse Myel... Friedreich Atax...	Seated exercise	18 Years - 75 Years	Burke Medical Research Institute
Improving Social Cognition and Social Behaviour in Various Brain Disorders	NCT06330298	Stroke Multiple Sclero... Brain Tumor	Treatment socia...	18 Years - 75 Years	University Medical Center Groningen

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: